anticonvulsant

Type: Keyphrase
Name: anticonvulsant
First reported 5 hours ago - Updated 5 hours ago - 1 reports

Anticonvulsant Strategies for Treating Bipolar Disorder: What Works, What Doesn't

ACTIVITY GOALThis article reviews the anticonvulsants that are part of the armamentarium for bipolar disorder.LEARNING OBJECTIVESAt the end of this CE activity, participants should be able to:1. Identify the anticonvulsants that have been studied for ... [Published Psychiatric Times - 5 hours ago]
First reported 6 hours ago - Updated 6 hours ago - 1 reports

VIVUS : Patent Issued for Combination Therapy for Treatment of Sleep Apnea

By a News Reporter-Staff News Editor at Diabetes Week -- Vivus, Inc. ( Mountain View, CA ) has been issued patent number 8802636, according to news reporting originating out of Alexandria, Virginia , by NewsRx editors (see also Vivus, Inc. ).The patent's ... [Published 4 Traders - 6 hours ago]
First reported 20 hours ago - Updated 20 hours ago - 1 reports

Transformation of Oxcarbazepine and Human Metabolites of Carbamazepine and Oxcarbazepine in Wastewater Treatment and Sand Filters

Carbamazepine (CBZ) and oxcarbazepine (OXC) are widely used anticonvulsants that are extensively metabolized in the human body. The pharmaceuticals and their human metabolites are present in influents and effluents of wastewater treatment plants (WWTPs), ... [Published Environmental Science & Technology - 20 hours ago]
First reported Aug 19 2014 - Updated Aug 19 2014 - 1 reports

Perampanel for epilepsy: Still no proof of added benefit

The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures). In a new early benefit assessment according to the Act on the Reform ... [Published Medical Xpress - Aug 19 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 1 reports

GABAA receptor modulators

The present invention relates to novel compounds of the general formula (I) having anxiolytic, anticonvulsant, sedative-hypnotic and myorelaxant conditions as well as anxiogenic, somnolytic and convulsant conditions in mammals, including humans, as GABAA ... [Published Free Patents Online - Aug 19 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 1 reports

Suitability of Becton Dickinson Vacutainer rapid serum tube for collecting and storing blood samples for antibiotic and anticonvulsant drug monitoring

AbstractAims To investigate the suitability of newly developed Becton Dickinson Vacutainer rapid serum tube (RST) for therapeutic drugmonitoring of antibiotics and anticonvulsants.Methods Two pools of citrated whole blood were created by spiking high ... [Published Journal of Clinical Pathology - Aug 19 2014]
First reported Aug 17 2014 - Updated Aug 17 2014 - 1 reports

Phobias may be best treated in the early morning

Specific phobias are among the most common anxiety disorders, affecting more than one in ten of the population London: People who had therapy for fear of spiders at 8am had a greater reduction in symptoms than those treated at 6pm, in a study at Saarland ... [Published Gulf News - Aug 17 2014]
First reported Aug 15 2014 - Updated Aug 15 2014 - 1 reports

I'm not high, I'm just hurting

I’ve wanted to write about the politics of pain for a while. As a sufferer of chronic pain, I find myself in a constant struggle with doctors and pharmacists who think they know what and how much pain meds I require. Even more difficult is the fight I ... [Published Daily Kos - Aug 15 2014]
First reported Jul 29 2014 - Updated Jul 29 2014 - 2 reports

Parents Gain Access to Marijuana Extract to Treat Childhood Seizures

April Sintz is fighting to loosen marijuana laws for her 7-year-old epileptic son[1]. She is one of hundreds of moms nationwide who have opened a new front in the drive to expand the drug’s legal use.While supplying pot to a child is bound to raise eyebrows, ... [Published DailyMe.Com - Jul 29 2014]
First reported Jul 28 2014 - Updated Jul 29 2014 - 3 reports

The Upsher-Smith Galaxy portfolio of antiepileptic drugs now available

Upsher-Smith Laboratories announced that it has launched the Upsher-Smith Galaxy, a new and growing suite of antiepileptic drugs (AEDs) that offers people with epilepsy consistent, affordable and accessible therapies. ... [Published PBR - News - Jul 29 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 2 reports

UCB reports positive data from epilepsy drug trial

:55 in Pharmaceutical Company Product News UCB has announced positive topline results from a phase III trial of brivaracetam, its new therapy for epilepsy patients with partial-onset seizures. The newest investigational medicine from UCB's late-stage ... [Published Zenopa - Jul 23 2014]
Entities: UCB SA, Epilepsy, Seizures, Drugs
First reported Jul 22 2014 - Updated Jul 22 2014 - 3 reports

Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome

LOS ANGELESThe trial is being conducted at the Olive View-UCLA Medical Center in Sylmar, CaliforniaLGS is a catastrophic form of childhood epilepsy characterized by three key features: multiple types of seizures, particularly "tonic" (stiffening) and ... [Published Bio-Medicine - Jul 22 2014]

Quotes

From the background information supplied by the inventors, news correspondents obtained the following quote: "About 97 million adults in the United States are overweight or obese. The medical problems caused by overweight and obesity can be serious and often life-threatening, and include diabetes, shortness of breath, gallbladder disease, hypertension, elevated blood cholesterol levels, cancer, arthritis, other orthopedic problems, reflux esophagitis (heartburn), snoring, sleep apnea, menstrual irregularities, infertility and heart trouble. Moreover, obesity and overweight substantially increase the risk of morbidity from hypertension, dyslipidemia, type 2 diabetes, coronary heart disease, stroke, gallbladder disease, osteoarthritis and endometrial, breast, prostate, and colon cancers. Higher body weights are also associated with increases in all-cause mortality. Most or all of these problems are relieved or improved by permanent significant weight loss. Longevity is likewise significantly increased by permanent significant weight loss."
...the Executive Secretariat of the Council of Ministers of Health of Central America and the Dominican Republic (SE-COMISCA), Maria de Los Angeles, "22 drugs will be negotiated with 9 international pharmaceutical companies, which will allow us to save costs, get quality drugs and ones that are affordable compared to other providers in the region. "
"Tonic-clonic seizures are very serious and can have a profound effect on quality of life for people with epilepsy. We believe that perampanel has great potential in this area and have filed in Europe"
"The report by IQWiG has neglected to take into account the German people with epilepsy who already experience an additional benefit with Fycompa. Considerable real world experience data is available in Germany, and I have personally witnessed and published about the additional benefit this treatment can bring to people with refractory epilepsy" commented Bernhard Steinhoff, a professor at Epilepsiezentrum Kork, Kehl-Kork, Germany

More Content

All (205) | News (178) | Reports (0) | Blogs (25) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
Opioids: Won't You Get Addicted? [Published Arthritis Self-Management - 1 hour ago]
Eisai sues FDA for ‘losing one year’ of marketi... [Published In-Pharmatechnologist - 1 hour ago]
Anticonvulsant Strategies for Treating Bipolar ... [Published Psychiatric Times - 5 hours ago]
VIVUS : Patent Issued for Combination Therapy f... [Published 4 Traders - 6 hours ago]
Central America: Joint Procurement of Medicines [Published CentralAmericaData - 8 hours ago]
Restless Legs Syndrome [Published MedicineNet.com - 13 hours ago]
Eisai Submits Applications for Antiepilepsy Age... [Published PredictWallStreet - 16 hours ago]
Transformation of Oxcarbazepine and Human Meta... [Published Environmental Science & Technology - 20 hours ago]
Eisai Submits EU Marketing Authorisation Applic... [Published ADVFN UK - 23 hours ago]
Inventor Phil Blizzard Reveals ThunderShirt's S... [Published Examiner.com - Aug 19 2014]
Perampanel for epilepsy: Still no proof of adde... [Published Medical Xpress - Aug 19 2014]
Family’s heartbreaking plea for medical cannabis [Published Daily Telegraph Australia - Central Coast - Aug 19 2014]
GABAA receptor modulators [Published Free Patents Online - Aug 19 2014]
Suitability of Becton Dickinson Vacutainer rapi... [Published Journal of Clinical Pathology - Aug 19 2014]
Drug binding to a bacterial Nav channel [Biophy... [Published PNAS - Aug 19 2014]
New Summary: Clinical practice guideline for th... [Published National Guideline Clearinghouse - Aug 18 2014]
Detailed guide: DVLA’s current medical guidelin... [Published Government UK - Aug 18 2014]
IQWiG again turns down Eisai’s epilepsy drug Fy... [Published Pharma Letter - Aug 17 2014]
Phobias may be best treated in the early morning [Published Gulf News - Aug 17 2014]
The Ketogenic Diet for Adults With Epilepsy [Published General Medicine eJournal - Aug 15 2014]
I'm not high, I'm just hurting [Published Daily Kos - Aug 15 2014]
Obesity & 25-Hydroxyvitamin D Deficiency in Cer... [Published General Medicine eJournal - Aug 14 2014]
Researchers from Scripps Research Institute Rep... [Published HispanicBusiness.com - Aug 14 2014]
8/12/2014 Researchers Identify Genetic Variant ... [Published Neurology Today - Aug 12 2014]
Marinus Pharmaceuticals, Inc. Enters Into Use A... [Published EMoneyDaily - Aug 12 2014]
Marinus Pharmaceuticals, Inc. Enters Into Use A... [Published Ask.com - Aug 12 2014]
4-hydroxybenzomorphans [Published Free Patents Online - Aug 12 2014]
Combination therapy for treatment of sleep apnea [Published Free Patents Online - Aug 12 2014]
Intracutaneous paste composition [Published PharmCast - Aug 12 2014]
Dealing with Seizures in Pets [Published Long Beach Post - Aug 11 2014]
1 2 3 4 5 6 7
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Parents Gain Access to Marijuana Extract to Tre... [Published Mashable! - Jul 29 2014]
April Sintz is fighting to loosen marijuana laws for her 7-year-old  epileptic son . She is one of hundreds of moms nationwide who have opened a new front in the drive to expand the drug’s legal use. While supplying pot to a child is bound to ...
The Upsher-Smith Galaxy portfolio of antiepilep... [Published PBR - News - Jul 29 2014]
Upsher-Smith Laboratories announced that it has launched the Upsher-Smith Galaxy, a new and growing suite of antiepileptic drugs (AEDs) that offers people with epilepsy consistent, affordable and accessible therapies. ...
The Upsher-Smith Galaxy™ Portfolio Of Antiepile... [Published PR Newswire: Health - Jul 28 2014]
MAPLE GROVE, Minn., July 28, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced that it has launched the Upsher-Smith Galaxy™, a new and growing suite of antiepileptic drugs (AEDs) that offers people with epilepsy ...
Levetiracetam for pain... no evidence of it wor... [Published Multiple Sclerosis Research - Jul 19 2014]
Levetiracetam is not effective in neuropathic pain. #MSBlog #MSResearch "The meta-analysis below shows that the anti-convulsant, levetiracetam, is not effective in neuropathic pain. This mirrors my experience in clinical practice with the drug. The ...
Upsher-Smith launches generic equivalent to Qud... [Published PBR - News - Jul 15 2014]
Upsher-Smith Laboratories (Upsher-Smith), has announced the launch of Topiramate Extended-Release Capsules, the authorized generic of the recently Food and Drug Administration (FDA) approved Qudexy XR (topiramate) extended-release capsules, a once-daily, ...
1 2 3 4 5
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.